[ET Net News Agency, 5 July 2024] HANSOH PHARMA (03692) rose 3% to HK$16.46, breaking
above the 10-D SMA of HK$16.292.
It hits an intra-day high of HK$16.46, and an intra-day low of HK$15.9. The total shares
traded was 1.58 million, with a value of HK$25.45m. The active buy/sell ratio is 72:28,
with net buying turnover of HK$10.55m. UBS accounts for greatest net responsive buying
turnover of HK$3.38m, with volume weighted average price of HK$16.155. DAIWA CAPITAL
MARKETS HK accounts for greatest net responsive selling turnover of HK$2.61m, with volume
weighted average price of HK$16.164. The stock has risen a combined 3.7% over the past 2
consecutive trading days.
The Hang Seng Index now fell 156 points, or 0.9% to 17,871.

Basic Information
=================

---------------------------------
Nominal 16.460 % Chg +3.00%
High 16.460 Low 15.900
Shares Tr 1.58m Turnover 25.45m
10-D SMA 16.292 %H.V 29.397
20-D SMA 16.821 VWAP 16.145
50-D SMA 17.066 RSI14 47.342
---------------------------------
Status: Breaking above the 10-D SMA, active buy/sell ratio is 72:28, with net buying
turnover of HK$10.55m, rising a combined 3.7% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
HANSOH PHARMA (03692) 16.46 +3.00
ALI HEALTH (00241) 3.18 -1.24
TRAD CHI MED (00570) 3.64 -0.82
CSPC PHARMA (01093) 6.23 +1.30
SINOPHARM (01099) 20.45 -1.21
SINO BIOPHARM (01177) 2.80 +2.56
WUXI APPTEC (02359) 29.10 +0.34
CHINARES PHARMA (03320) 5.69 -0.35
JD HEALTH (06618) 21.45 -0.92
GOLDEN THROAT (06896) 3.12 -0.32
-----------------------------------------------
(ed)